Tectonic Therapeutic | AVRO - Ebitda


Tectonic Therapeutic reported $-21.18M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alnylam Pharmaceuticals USD 145.22M 236.56M Dec/2025
Celltrion KRW 17.79B 356.77B Dec/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Divis Laboratories Ltd INR 9.34B 440M Mar/2026
Gilead Sciences USD 3.02B 1.01B Dec/2025
Ionis Pharmaceuticals USD -200.02M 42.89M Dec/2025
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
MacroGenics USD 21.95M 55.39M Sep/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Organigram Holdings CAD 5.26M 884K Dec/2025
Pfizer USD 5.99B 5.23B Mar/2026
Pharma Mar EUR 2.71M 42.25M Mar/2026
Qiagen NV USD 249.69M 56.53M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
Sarepta Therapeutics USD -252.2M 84.16M Dec/2025
Sartorius EUR 267.3M 10.1M Mar/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Takeda JPY 150.25B 297.88B Mar/2026
Tilray USD 8.36M 1.82M Sep/2025
Zealand Pharma A/S -727.47M 285.54M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026